Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
about
Microglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics?Does neuroinflammation fan the flame in neurodegenerative diseases?Upregulation of SYF2 is associated with neuronal apoptosis caused by reactive astrogliosis to neuroinflammationS100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model.Ionizing Radiation-Induced Immune and Inflammatory Reactions in the Brain.Omega-3 fatty acids and cognitive function in women.Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology.Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease.Antioxidant and acetylcholinesterase-inhibitory properties of long-term stored medicinal plants.Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian PopulationSynaptic change in the posterior cingulate gyrus in the progression of Alzheimer's diseaseExpression profiles for macrophage alternative activation genes in AD and in mouse models of ADThe Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.A standardized randomized 6-month aerobic exercise-training down-regulated pro-inflammatory genes, but up-regulated anti-inflammatory, neuron survival and axon growth-related genes.Neuroinflammation in Alzheimer's disease wanes with ageReelin-mediated Signaling during Normal and Pathological Forms of AgingOcular manifestations of Alzheimer's disease in animal models.Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseasesBeta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice.Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammationBeneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster.Microglia and inflammation in Alzheimer's disease.The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout.The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.Upregulation of PRDM5 Is Associated with Astrocyte Proliferation and Neuronal Apoptosis Caused by Lipopolysaccharide.Microglial phenotypes in Parkinson's disease and animal models of the disease.Neochlorogenic Acid Inhibits Lipopolysaccharide-Induced Activation and Pro-inflammatory Responses in BV2 Microglial Cells.Biochanin A inhibits lipopolysaccharide-induced inflammatory cytokines and mediators production in BV2 microglia.Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.The expression pattern of Nischarin after lipopolysaccharides (LPS)-induced neuroinflammation in rats brain cortex.Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets.Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease.Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance.Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.
P2860
Q26739495-99B1AE16-1A98-4EA5-85EF-0C6043796AD9Q27498993-CD9328A0-480B-48D9-BF57-C3722CD0547AQ28566010-D3713F51-F546-4FF1-AE46-A9D2C7512C8CQ33526262-41327082-0568-49FC-960C-14277686AB9EQ33639101-BDD9BC72-A1CF-464C-BFF9-1B4EED852555Q33677382-D8BDF4C3-B1E5-4B58-B523-128D85B7ECB6Q34169743-12126033-C94D-4320-8988-D8C26E6DCEEAQ34201803-8343BBE0-7B07-4981-BA6F-782A404EE70DQ34329415-E5AB2B17-07B6-43F8-90DA-5DB7131F4049Q34471418-63E19F67-2C3D-4F63-9DB0-7CC6534BE868Q35035669-214FB410-87C1-4888-9792-F7163F4906B8Q35090548-47562B49-C4BD-48DC-8976-EC5287668FCBQ35327219-46052119-B50B-47E7-8269-5B265AA2EDD1Q35599843-2C278819-E6F1-49B1-80AE-43B7CF825CC7Q35633686-8B984927-52B1-4527-876F-237539FC59A4Q35640906-431E0C4E-090E-448B-BF0A-E504848545E5Q35806690-41235D97-C5CC-4759-ADBE-0A0CEF0BCCF0Q35993835-C4DCD817-A111-4A20-8637-DFBDA8910A59Q36479597-1135B942-6E65-4572-833E-EE40BE78249AQ36968718-68B1E401-0A10-4A96-AC06-5B05DC23A5A4Q37069901-836E0D6F-109F-47C9-B39F-34A121FC661BQ37151427-68E8262E-F1A7-4443-936B-A792C2AB4CDCQ37293041-962CB9FE-730C-41D8-A544-57C25090CAE7Q37462091-86743783-5A78-433D-A4AD-E6EB74E950FBQ37703295-ED0B7C8D-EAB2-474E-BAA8-82044F92CE05Q37981036-2EBBD88D-1E9C-49D1-9CF7-1202AE83DBDCQ38094984-E0514251-3560-41FF-A78D-66AE63B81C6AQ38097932-5E1FC599-A3AB-449E-B486-9F66A0156E6FQ38668948-624C3CFD-97B2-49FA-8CA6-61E1EA9C8B6BQ38778542-BDE6C612-BFA2-4031-AD11-B64BE152F5E4Q38815779-381D00A5-0150-47AC-BCAB-6267B5A5B043Q38855685-08CF3CB1-CE48-4979-A87D-1F590379DD07Q38937107-95EE7D60-4F47-49AE-876D-D17C84DBAED2Q38955402-679D1E87-E1AD-461A-8952-15D6176021D4Q39092159-AFD90D88-B536-4E15-8FC2-E33206BD1185Q41816654-48D00C19-E041-444B-80CD-C87768D232ABQ41864750-303B27C7-2CD9-49A0-A7EF-5FB468574ECBQ42026475-8BA66DF8-34DC-4B6F-8BBC-CCDBF2D119F2Q42119910-8B1B23E7-CA67-4AF5-8E10-7EC6C426B35BQ42123997-75AA6790-6240-41ED-8FBB-D88CFBA0BAA9
P2860
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
@ast
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
@en
type
label
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
@ast
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
@en
prefLabel
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
@ast
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
@en
P2093
P1476
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
@en
P2093
Eikelenboom P
Rozemuller JM
Veerhuis R
P304
P356
10.1016/J.IJDEVNEU.2005.11.001
P577
2005-12-27T00:00:00Z